Skip to main content

Acutus Medical, Inc.

AFIBDelisted May 16, 2024
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001522860

Acutus Medical, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Jan 28, 2025; 23 institutions reported holding it in 13F filings for Q1 2024, worth $1.24M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Acutus Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Acutus Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Acutus Medical, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Deerfield Management Company, L.P.Director, Other: Director by deputization20,822IndirectJan 28, 20250
Flynn James EDirector, Other: Director by deputization20,822IndirectJan 28, 20250
Mukai TakeoCFO72,874Mar 4, 20240
Sohn TomSVP, Gen. Counsel & Secretary105,009Feb 7, 20240
Mathews KevinSVP, Commercial61,106Jan 18, 20240
Roman DavidPresident & CEO332,134Jan 18, 20240
ElBardissi AndrewDirector20,822Jun 29, 20230
Sheridan John FDirector24,347Jun 15, 20230
Huennekens R ScottDirector21,840Jun 15, 20230
Bonita David PDirector20,822Jun 15, 20230
Pellegrini Niamh LouiseDirector20,972Jun 15, 20230
Garland Jason KDirector22,400Jun 15, 20230
Marzouk ShadenDirector20,822Jun 15, 20230
Piscitello CharlieSVP, Chief People Officer85,683Apr 4, 20230
Deerfield Mgmt L.P.Director, 10% Owner, Other: Director by Deputization3,438,589IndirectJul 5, 20220
Deerfield Partners, L.P.Director, 10% Owner, Other: Director by Deputization3,438,589IndirectJul 5, 20220
Deerfield Private Design Fund III, L.P.Director, 10% Owner, Other: Director by Deputization3,438,589IndirectJul 5, 20220
Deerfield Mgmt III, L.P.Director, 10% Owner, Other: Director by Deputization3,438,589IndirectJul 5, 20220
Hinrichs James F.Director61,311Jun 21, 20220
Cramp DaniellaDirector11,623Jun 21, 20220
Burgess Vincent JChief Executive Officer61,469Apr 5, 20220
McQuillan StevenSVP, Clinical Affairs & QA45,844Apr 5, 20220
OrbiMed Advisors LLCDirector, 10% Owner1,677,361IndirectJul 21, 20210
OrbiMed Capital GP IV LLCDirector, 10% Owner1,677,361IndirectJul 21, 20210
Orbimed ROF II LLCDirector, 10% Owner1,677,361IndirectJul 21, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 3, 2022 (view filing)Jun 3Same dayHuennekens R ScottDirectorSSale−60.0K$0.58−$34.8K−10.6%507.5K after
Nov 17, 2021 (view filing)Nov 152 daysHinrichs James F.DirectorPPurchase+40.0K$3.78+$151.2K+309.8%52.9K after
Jul 21, 2021 (view filing)5:30 PM ETJul 192 daysOrbiMed Advisors LLC and 2 othersDirector, 10% OwnerPPurchase+1.07M$14.00+$15.0M+176.8%1.68M after2 lotsDuplicate filing
Jul 21, 2021 (view filing)5:14 PM ETJul 192 daysDeerfield Management Company, L.P. and 5 othersDirector, 10% Owner, Other: Director by DeputizationPPurchase+1.07M$14.00+$15.0M+45.3%3.44M after2 lots
Jul 21, 2021 (view filing)Jul 192 daysBonita David PDirector, 10% OwnerPPurchase+1.07M$14.00+$15.0M+176.8%1.68M after2 lots